Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

2.

Dissociative identity disorder: method or fact?

3.

New Gene Therapy Nears EU Nod for Bladder Cancer

4.

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

5.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot